Lilly Focuses Xigris Promotion On Physician “Peer-To-Peer” Discussions

Lilly believes "peer-to-peer" discussions about positive experiences with Xigris will energize sales of the sepsis agent, Exec VP-Pharmaceutical Products & Corporate Development John Lechleiter, PhD, said